Macerich invests in premium mall assets... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XBI | 147.86 | 3.54 | +2.45% |
| State Street SPDR S&P Biotech ETF (XBI) | |||
| IETC | 108.30 | 1.71 | +1.61% |
| iShares U.S. Tech Independence Focused ETF (IETC) | |||
| MSFY | 21.53 | 0.20 | +0.96% |
| Kurv Yield Premium Strategy Microsoft (MSFT) ETF (MSFY) | |||
| NBTR | 47.90 | -0.13 | -0.27% |
| Neuberger Berman Total Return Bond ETF | |||
| XMPT | 19.61 | -0.09 | -0.46% |
| VanEck CEF Muni Income ETF (XMPT) | |||
A.I.dvisor indicates that over the last year, MAC has been closely correlated with CUZ. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if MAC jumps, then CUZ could also see price increases.
a real estate investment trust
Industry RealEstateInvestmentTrusts
The Moving Average Convergence Divergence (MACD) for MAC turned positive on September 21, 2026. Looking at past instances where MAC's MACD turned positive, the stock continued to rise in 39 of 53 cases over the following month. The odds of a continued upward trend are 74%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MAC's RSI Oscillator exited the oversold zone, 15 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 56%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 42 of 59 cases where MAC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
Following a +1.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where MAC advanced for three days, in 219 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
MAC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MAC as a result. In 61 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MAC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for MAC entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. MACβs price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.303) is normal, around the industry mean (2.662). MAC has a moderately low P/E Ratio (-34.788) as compared to the industry average of (34.750). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (12.808). Dividend Yield (0.030) settles around the average of (370.996) among similar stocks. P/S Ratio (5.807) is also within normal values, averaging (6.739).
The Tickeron Profit vs. Risk Rating rating for this company is 55 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.